Voyager Therapeutics, Inc. (VYGR) Profit Margins
Over the twelve months to 2026-06-30, Voyager Therapeutics, Inc. (VYGR) had operating margin -340.1%, net margin -312.6%, free cash flow margin -352.4%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
VYGRVoyager Therapeutics, Inc.Follow VYGR — free
—
Price chart with a free account
- Market cap
- 107.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -116.8% | -290.4% | -709.1% | -1195.6% | -49.5% | 16.0% | -196.8% | -124.3% | 48.8% | -104.1% | -326.6% | -340.1% | |
| Net margin | -171.2% | -282.7% | -697.6% | -1158.8% | -41.8% | 21.5% | -190.3% | -113.4% | 52.9% | -81.3% | -296.5% | -312.6% | |
| FCF margin | 232.3% | -334.1% | -644.6% | -265.0% | 39.2% | -63.6% | -147.4% | -36.7% | 29.9% | -23.5% | -334.5% | -352.4% |
USD millions · SEC XBRL
Voyager Therapeutics, Inc. — questions
- What is Voyager Therapeutics, Inc.'s operating margin?
- -340.1% over the twelve months to 2026-06-30.
- What is Voyager Therapeutics, Inc.'s net profit margin?
- -312.6% over the twelve months to 2026-06-30.
Every figure on this page comes from Voyager Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.